Webinar on-demand: Scalable Logistics for Cell and Gene Therapies
By World Courier
Using case studies and then applying academic principles, this webinar looks at the value of planning logistics early in the development of cell and gene therapies.
More traditional therapies have elongated clinical trials and established supply chains. However cell and gene therapies are moving from Phase I to marketing authorization application in 5 years, and have complicated temperature-critical, time-sensitive logistics requirements.
It is valuable, therefore, to have a vision for the commercial supply chain and use the clinical trial process to build, test and optimize the logistics platform ready for commercial launch.
Learning Outcomes
The value of planning early
The impact of poor logistics on a therapy's ability to treat patients
The complexity of cell and gene therapy supply chains
How to develop a logistics platform that can support clinical trials but be able to grow into commercial scale
In Collaboration with
 |
 |
Speakers
 |
Joshua Anderson Senior Manager, Clinical Supply Operations Adaptimmune |
 |
Simon Ellison Cell and Gene Therapy Service Director World Courier |
 |
Ryan McCoy Lead Technical Scientist Cell and Gene Therapy Catapult |
